Author Benefits

WHY PUBLISH WITH ADVANCES IN REGENERATIVE BIOLOGY (ARB)?

  • Double-blind peer review – ARB applies a double-blind peer review process to ensure a fair and equitable scholarly review of your work.
  • Open Access – ARB is free from all access barriers, allowing for the widest possible global dissemination of your work.
  • Rapid publication process – upon acceptance of your article, you can expect it to be online (officially published) within 3-4 weeks.
  • Retain copyright – you retain copyright and are free to disseminate your article, make copies for any use, and/or deposit in any repository or archive you like.
  • Comply with Open Access policies –ARB complies with funder-based and institutional Open Access policies.
  • Add supplementary material – ARB welcomes data sets, protocols, videos, questionnaires, etc. as supplementary material to your article at  no charge. Contact the publisher if you would like to discuss any of these.


WHY OUR ADVISORY BOARD MEMBERS SUPPORT ARB

“This is crucial time in cell biology: new methodologies have led to a deeper understanding of how cell acquire their identity, divide, migrate, produce their extra-cellular matrix and eventually differentiate or die. This has enabled us to exploit this knowledge in different fields such as regenerative biology and medicine. This scenario is appropriate for launching a new journal on regenerative biology that will be characterized by rapid, accurate and transparent peer review and by the aim to become soon a leading journal in the field.”
Giulio Cossu, Institute of Inflammation and Repair, University of Manchester, UK

 

"Due to the improved understanding of the complex biological processes by which animals can regenerate tissues and organs, it has become possible to envisage a future where parts of the human body that have sustained injury might ultimately be replaced. Advances in Regenerative Biology is a timely and much needed addition to report and disseminate knowledge in the field of regenerative medicine. "
Juan Carlos Izpisua Belmonte, The Salk Institute for Biological Studies, La Jolla, USA.

 

"This is an exciting time in regenerative biology and I welcome the arrival of a new and ambitious open access journal focusing on this topic."
Jonas Frisén, Department of Cell and Molecular Biology
Karolinska Institutet, Stockholm, Sweden

 

"Given the emergence of new technologies that have opened new avenues of research in regenerative biology it is timely to welcome a new high level journal based on the principles of transparency and reproducibility with a focus on this important topic."
Fred H. Gage, The Salk Institute for Biological Studies, La Jolla, USA